NCT02805842View on ClinicalTrials.gov

Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus

PHASE3UnknownINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions

Medication Adherence

Interventions

DRUG

Tacrolimus BID

Administration of Tacrolimus BID

DRUG

Advagraf QD

administration of Advagraf QD

Trial Locations (1)

4100

Rabin Med Ctr, Petah Tikva

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

collaborator

Teva Pharma

INDUSTRY

lead

Rabin Medical Center

OTHER

NCT02805842 - Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus | Biotech Hunter | Biotech Hunter